These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 14871994)
1. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994 [TBL] [Abstract][Full Text] [Related]
2. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623 [TBL] [Abstract][Full Text] [Related]
3. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells. Takai N; Ueda T; Nishida M; Nasu K; Narahara H Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156 [TBL] [Abstract][Full Text] [Related]
4. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035 [TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Sakajiri S; Kumagai T; Kawamata N; Saitoh T; Said JW; Koeffler HP Exp Hematol; 2005 Jan; 33(1):53-61. PubMed ID: 15661398 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Wu Y; Guo SW Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583 [TBL] [Abstract][Full Text] [Related]
9. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis. Takai N; Narahara H Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707 [TBL] [Abstract][Full Text] [Related]
10. DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo. Yi TZ; Li J; Han X; Guo J; Qu Q; Guo L; Sun HD; Tan WH Chemotherapy; 2012; 58(1):19-29. PubMed ID: 22343305 [TBL] [Abstract][Full Text] [Related]
11. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY; Jung JH; Na YJ; Kim HS Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664 [TBL] [Abstract][Full Text] [Related]
12. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells. Ueda T; Takai N; Nishida M; Nasu K; Narahara H Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205 [TBL] [Abstract][Full Text] [Related]
13. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Kawano Y; Nasu K; Li H; Tsuno A; Abe W; Takai N; Narahara H Hum Reprod; 2011 Sep; 26(9):2486-98. PubMed ID: 21715447 [TBL] [Abstract][Full Text] [Related]
14. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. Herold C; Ganslmayer M; Ocker M; Hermann M; Geerts A; Hahn EG; Schuppan D J Hepatol; 2002 Feb; 36(2):233-40. PubMed ID: 11830335 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells. Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Butler LM; Webb Y; Agus DB; Higgins B; Tolentino TR; Kutko MC; LaQuaglia MP; Drobnjak M; Cordon-Cardo C; Scher HI; Breslow R; Richon VM; Rifkind RA; Marks PA Clin Cancer Res; 2001 Apr; 7(4):962-70. PubMed ID: 11309347 [TBL] [Abstract][Full Text] [Related]
18. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270 [TBL] [Abstract][Full Text] [Related]
20. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. Chen YX; Fang JY; Lu J; Qiu DK Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]